Cristina Bergamaschi

4PUBLICATIONS
32CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunitySeparation technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 20, 2021
Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors.

Kevin Conlon, Dionysios C Watson, Thomas A Waldmann

|Mar 06, 2021
Heterodimeric IL-15 in Cancer Immunotherapy.

Cristina Bergamaschi, Vasiliki Stravokefalou, Dimitris Stellas

|May 29, 2020
Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.

Cristina Bergamaschi, Hrishikesh Pandit, Bethany A Nagy

|Mar 15, 2018
Scalable, cGMP-compatible purification of extracellular vesicles carrying bioactive human heterodimeric IL-15/lactadherin complexes.

Dionysios C Watson, Bryant C Yung, Cristina Bergamaschi

Pageof 1

Frequent Collaborators

3 joint publications

Dimitris Stellas

3 joint publications

Barbara K Felber

3 joint publications

George N Pavlakis

2 joint publications

Dionysios C Watson